|
⚲
|
| Keyboard |
| Marquez Octavio
✚
|
|
|---|---|
| CIK # | 0001917170 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001917170] | |
| 4 | [0001917170] | |
| 5 | [0001917170] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Marquez Octavio | |
| Diebold Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Diebold Inc DBD
Common Stock
|
2026-03-07 | Tax withheld | 10,549 | $77.58 | 818,391 |
|
Diebold Inc DBD
Common Stock
|
2026-03-01 | Tax withheld | 9,119 | $80.00 | 729,520 |
|
Diebold Inc DBD
Common Stock
|
2026-03-01 | Grant | 44,286 | $0.00 | |
|
Diebold Inc DBD
Common Stock
|
2026-01-19 | Tax withheld | 3,136 | $69.91 | 219,238 |
|
Diebold Inc DBD
Common Stock
|
2025-03-07 | Tax withheld | 9,036 | $43.73 | 395,144 |
|
Diebold Inc DBD
Common Stock
|
2025-03-01 | Grant | 69,523 | $0.00 | |
|
Diebold Inc DBD
Common Stock
|
2025-01-19 | Tax withheld | 3,176 | $44.49 | 141,300 |
|
Diebold Inc DBD
Common Stock
|
2024-11-12 | Buy | 1,199 | $40.95 | 49,099 |
|
Diebold Inc DBD
Common Stock
|
2024-11-12 | Buy | 491 | $40.57 | 19,920 |
|
Diebold Inc DBD
Common Stock
|
2024-08-09 | Buy | 1,100 | $37.34 | 41,074 |
|
Diebold Inc DBD
Common Stock
|
2024-05-06 | Buy | 278 | $38.89 | 10,811 |
|
Diebold Inc DBD
Common Stock
|
2024-05-06 | Buy | 235 | $38.92 | 9,146 |
|
Diebold Inc DBD
Common Stock
|
2024-03-14 | Buy | 500 | $33.80 | 16,900 |
|
Diebold Inc DBD
Common Stock
|
2024-03-13 | Buy | 978 | $34.27 | 33,516 |
|
Diebold Inc DBD
Common Stock
|
2024-03-13 | Buy | 22 | $34.18 | 752 |
|
Diebold Inc DBD
Common Stock
|
2024-03-07 | Grant | 80,423 | $0.00 | |
|
Diebold Inc DBD
Common Stock
|
2024-01-19 | Grant | 50,088 | $0.00 | |
|
Diebold Inc DBD
Employee Stock Option (right to buy) · derivative
|
2024-01-19 | Grant | 250,443 | $0.00 | |
|
Diebold Inc DBD
Common Stock
|
2023-12-29 | Small acquisition | 10 | $28.84 | 288 |
|
Diebold Inc DBD
Common Stock
|
2023-12-18 | Small acquisition | 14 | $27.67 | 387 |
| showing 20 of 45 most recent transactions | |||||